Nepean Dyspepsia Index (NDI): A Full Guide for Researchers and Clinicians
By ResRef
Published
Learn about the Nepean Dyspepsia Index (NDI): what it measures, how it is scored and interpreted, and how researchers and clinicians use it.
Introduction
Functional dyspepsia often disrupts daily life with persistent upper abdominal discomfort, bloating, and related symptoms. Therefore, the Nepean Dyspepsia Index (NDI) emerges as an essential instrument for quantifying these impacts. Developed by Nicholas J. Talley and colleagues, this 42-item questionnaire, first validated in 1999, focuses on dyspepsia-specific symptoms and their effects on quality of life. Moreover, with over 300 citations on Google Scholar, its robust design and psychometric strength establish it as a cornerstone for researchers and clinicians in gastroenterology. Consequently, this article offers a thorough overview of the NDI, exploring its structure, applications, and value in advancing patient management for functional dyspepsia.
Key Features of the Nepean Dyspepsia Index (NDI)
Purpose and Use
The NDI specifically evaluates dyspepsia-related symptoms and quality of life. Consequently, it includes symptom items and quality-of-life items, setting it apart from general gastrointestinal tools by honing in on functional dyspepsia's unique burdens.
Target Population
The NDI primarily suits adults aged 18 and older with functional dyspepsia, including:
Young Adults (18-24 years)Middle-Aged Adults (25-44 years)Older Adults (45-64 years)Seniors (+65 years)However, it lacks validation for pediatric populations or those under 18, and further testing is needed for non-dyspeptic groups.
Structure
The NDI encompasses either 42 or 25 items depending on the version, divided into two main sections:
Symptom section: Rates frequency (0-4), severity (0-5), and bothersomeness (0-4) for symptoms such as epigastric pain, bloating, and nausea.Quality-of-life section (25 items): Employs a 5-point Likert scale (1 = not at all, 5 = extremely) across five subscales:Interference with daily activities (how much the symptoms disrupt your everyday life)Eating/drinking (ability to eat or drink normally)Knowledge/control over symptoms / disease (how much you feel you understand or can control your condition)Pain, discomfort, or sleep disturbancePsychological impact: tension / anxiety, emotional burden due to dyspepsia.Scoring Method
The NDI applies tailored scoring for symptoms and quality of life, using a 5-point Likert scale for each item:
1= Not at all/Never
5 = Extremely/Very often
First, symptom scores aggregate frequency, severity, and bothersomeness per item to generate a total symptom index. Next, quality-of-life scores span 0 to 100, with elevated scores denoting diminished quality of life. Subscales derive from summing pertinent items, enabling pinpointing of issues like disruptions in eating. For example, a prominent score in the interference subscale could signal the need for behavioral adjustments. While no standard cutoffs prevail, investigators frequently deem 10-point shifts as clinically significant or employ percentiles to highlight substantial dyspepsia effects.
Notably, higher scores = Better quality of life (less dyspepsia impact)
Administration Format
The NDI usually requires 10-15 minutes to finish, making it practical for demanding clinical workflows. Moreover, providers can administer it via:
Paper-based questionnaires.Digital platforms.In-person interviews.Notably, the questionnaire is self-administered, requiring no specialized training for administration or interpretation.
Applications of Nepean Dyspepsia Index (NDI)
The NDI provides flexible uses:
Screening: Identifies patients facing considerable dyspepsia consequences warranting deeper assessment.Monitoring: Tracks evolutions in symptoms and quality of life during therapies or over time.Treatment Planning: Shapes customized interventions drawing from subscale data.Research: Bolsters investigations into dyspepsia trajectories and therapies.Therefore, practitioners could tackle elevated eating/drinking scores through nutritional guidance, whereas scholars scrutinize patterns to optimize gastroenterology guidelines.
Language and availability
To facilitate international adoption, the NDI exists in translations such as:
ArabicChineseEnglishSpanishFrenchIndonesianKoreanHindiThis linguistic diversity enhances its utility in varied research and clinical environments.
Additionally, the NDI is free for non-commercial use, however, commercial or large-scale applications may require permission and potential fees.
Reliability and Validity
Validation studies uphold the NDI's solid attributes, revealing strong internal consistency, with Cronbach's alpha ranges between 0.85-0.92. Thus, its responsiveness to dyspepsia alterations renders its trustworthy for longitudinal gastrointestinal evaluations.
Original validation study: linkThe development of a 10-item short form: linkChinese version: linkIndonesian version: linkIndian version: linkLimitations and Considerations
Despite its strengths, the NDI has a few limitations:
Length: Some patients may find the 42-item questionnaire lengthy.Self-report: Respondents may be influenced by social desirability bias or personal interpretation.Limited Psychological Focus: It may not capture all psychological factors, especially in patients with fluctuating symptoms.Age Restrictions: Primarily validated for adults aged 18 and older, limiting applicability in pediatric or adolescent dyspepsia cases.Cultural Bias: Developed in Western contexts, it may exhibit biases in non-Western populations, necessitating further cross-cultural validations to ensure equitable use.Other Versions And Related Questionnaires
The NDI pairs effectively with alternatives like:
Short-Form Nepean Dyspepsia Index (SF-NDI): A condensed 10-item edition for expedited evaluations.Leeds Dyspepsia Questionnaire (LDQ): Emphasizes symptom intensity.Gastrointestinal Quality of Life Index (GIQLI): Provides a wider GI perspective, synergizing with the NDI for thorough appraisals.Additional Resources
For more information on the NDI, explore these resources:
Original Validation StudyYou can access the questionnaire as a PDF through this link .For inquiries, contact Nicholas J. Talley, the first author of the questionnaire at Talley@newcastle.edu.auFor additional NDI resources, consult Mapi Research Trust.Frequently Asked Questions (FAQ)
Who can use the NDI?Clinicians, researchers, and healthcare providers use the NDI for patients aged 18 and older with gastrointestinal diseases.
How long does it take to complete the NDI?Patients typically take 10 to 15 minutes to complete the NDI, which makes it feasible for use in clinical and research settings.
How is the NDI administered?Healthcare teams can administer the questionnaire via paper, digital, or mobile app formats—offering flexibility in usage.
Is there any cost to using the NDI?The NDI is free for non-commercial use. For commercial or funded academic projects, permission from the publisher may be necessary.
A word from ResRef about Nepean Dyspepsia Index (NDI)
The Nepean Dyspepsia Index (NDI) offers a reliable, validated, and comprehensive tool for assessing quality of life in patients with gastrointestinal conditions. Whether you are a researcher evaluating disease impact or a clinician improving patient care, the NDI reveals critical areas that need attention. Consequently, it leads to better outcomes and informed treatment decisions.
References
Talley, N. J., Verlinden, M., & Jones, M. (1999). Validity of a new quality of life scale for functional dyspepsia: A United States multicenter trial of the Nepean Dyspepsia Index. The American Journal of Gastroenterology, 94(9), 2390–2397. linkTalley, N.J., Verlinden, M. and Jones, M. (2001), Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Alimentary Pharmacology & Therapeutics, 15: 207-216. linkTian, X. P., Li, Y., Liang, F. R., Sun, G. J., Yan, J., Chang, X. R., Ma, T. T., Yu, S. Y., & Yang, X. G. (2009). Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China. World Journal of Gastroenterology, 15(25), 3173–31 linkArinton, I. G., et al. "The Nepean Dyspepsia Index: Translation and Validation in Indonesian Language." Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, vol. 7, Aug. 2006, pp. 38-41, linkGoyal, O., Goyal, P., Kishore, H. et al. Quality of life in Indian patients with functional dyspepsia: Translation and validation of the Hindi version of Short-Form Nepean Dyspepsia Index. Indian J Gastroenterol 41, 378–388 (2022). link